Finance

Beta
Lists
MLTX:NASDAQ
MoonLake Immunotherapeutics
$19.19
+2.68%
(+0.50) 1D
$19.00
-0.99% (-0.19)
After hours
Closed: Jun 15, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MLTX...
Open
$19.00
High
$19.21
Low
$18.65
Mkt. cap
1.41B
Avg. vol.
908.39K
Volume
576.15K
52-wk high
$62.75
52-wk low
$5.95
EPS
-$3.87
Beta
1.05
Shares outstanding
73.62M
No. of employees
130
Open
$19.00
High
$19.21
Low
$18.65
Mkt. cap
1.41B
Avg. vol.
908.39K
Volume
576.15K
52-wk high
$62.75
52-wk low
$5.95
EPS
-$3.87
Beta
1.05
Shares outstanding
73.62M
No. of employees
130
Analyst outlook
Analyst Ratings
Based on 12 analysts giving stock ratings to MLTX in the past 3 months
Buy
Buy
9
Hold
1
Sell
2
12 month forecast
Based on 12 Wall Street analysts offering 12 month price targets for MLTX in the last 3 months.
Highest
Current $19.19
$70.00 (+264.77%)
Average
$30.91 (+61.07%)
Lowest
$6.00 (-68.73%)
News stories
From sources across the web
About MoonLake Immunotherapeutics
CEO-
Employees130
Founded2020
HeadquartersZug, Zug, Switzerland
SectorBiotechnology
Websitemoonlaketx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
49.76M
60.64M
56.01M
54.52M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.94M
10.80M
9.21M
15.51M
Operating expense
60.70M
71.43M
65.22M
70.02M
Total operating expenses
60.70M
71.43M
65.22M
70.02M
Operating income
-60.70M
-71.43M
-65.22M
-70.02M
Other non operating income
6.40M
4.32M
3.92M
3.15M
EBT including unusual items
-55.96M
-70.58M
-62.77M
-69.08M
EBT excluding unusual items
-55.96M
-70.58M
-62.77M
-69.08M
Income tax expense
95.00K
115.00K
248.00K
622.00K
Effective tax rate
-0.17%
-0.16%
-0.40%
-0.90%
Other operating expenses
-
-
-
-
Net income
-55.22M
-69.73M
-62.43M
-69.71M
Net profit margin
-
-
-
-
Earnings per share
-0.87
-1.10
-0.92
-0.98
Interest and investment income
-
-
-
-
Interest expense
-2.04M
-3.20M
-1.99M
-2.27M
Net interest expenses
-2.04M
-3.20M
-1.99M
-2.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
-59.96M
-70.69M
-64.47M
-69.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer